Researchers at the University of California, Irvine (UCI) have developed a device that may be used in growing and forming a novel hybrid heart valve developed at UCI. The hybrid heart valve is capable of self-renewal and may be used as a replacement heart valve in patients. The device allows for the controlled application of different layers of cells to the form the hybrid heart valve. The device has also the capability to be used for culturing other types of tissue engineered valves that traditionally require a use of scaffold for formation.
|United States Of America||Issued Patent||10,016,461||07/10/2018||2013-324|
|United States Of America||Issued Patent||9,925,296||03/27/2018||2011-607|
|United States Of America||Issued Patent||8,936,650||01/20/2015||2011-607|
|United States Of America||Issued Patent||8,900,862||12/02/2014||2011-607|
|United States Of America||Published Application||20150081012||03/09/2015||2011-607|